Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion type Assertion NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_head.
- NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion description "[The ENPP1 121Gln and IRS-1 972Arg polymorphisms affecting insulin receptor activity predispose to liver damage and decrease hepatic insulin signalling in patients with NAFLD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_provenance.
- NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion evidence source_evidence_literature NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_provenance.
- NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion SIO_000772 20176643 NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_provenance.
- NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion wasDerivedFrom befree-20150227 NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_provenance.
- NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_assertion wasGeneratedBy ECO_0000203 NP515550.RAbJiu4s00EXDe_XrLAFh4158K9DXyZf5dEV8vnynU-MI130_provenance.